Inviting Free-Riders or Appealing to Prosocial Behavior? Game-Theoretical Reflections on Communicating Herd Immunity in Vaccine Advocacy

被引:136
作者
Betsch, Cornelia [1 ]
Boehm, Robert [1 ]
Korn, Lars [2 ]
机构
[1] Univ Erfurt, Ctr Empir Res Econ & Behav Sci CEREB, D-99089 Erfurt, Germany
[2] Univ Erfurt, Dept Psychol, D-99089 Erfurt, Germany
关键词
public health; immunization; social dilemma; advocacy; communication strategies; INFLUENZA VACCINATION; HEALTH BEHAVIOR; RISK PERCEPTION; MODEL; DECISIONS; ALTRUISM;
D O I
10.1037/a0031590
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: Vaccination yields a direct effect by reducing infection, but also has the indirect effect of herd immunity: If many individuals are vaccinated, the immune population will protect unvaccinated individuals (social benefit). However, due to a vaccination's costs and risks, individual incentives to free-ride on others' protection also increase with the number of individuals who are already vaccinated (individual benefit). The objective was to assess the consequences of communicating the social and/or individual benefits of herd immunity on vaccination intentions. We assume that if social benefits are salient, vaccination intentions increase (prosocial behavior), whereas salience of individual benefits might decrease vaccination intentions (free-riding). Methods: In an online-experiment (N = 342) the definition of herd immunity was provided with one sentence summarizing the gist of the message, either making the individual or social benefit salient or both. A control group received no information about herd immunity. As a moderator, we tested the costs of vaccination (effort in obtaining the vaccine). The dependent measure was intention to vaccinate. Results: When a message emphasized individual benefit, vaccination intentions decreased (free-riding). Communication of social benefit reduced free-riding and increased vaccination intentions when costs to vaccinate were low. Conclusions: Communicating the social benefit of vaccination may prevent free-riding and should thus be explicitly communicated if individual decisions are meant to consider public health benefits. Especially when vaccination is not the individually (but instead collectively) optimal solution, vaccinations should be easily accessible in order to reach high coverage.
引用
收藏
页码:978 / 985
页数:8
相关论文
共 45 条
[21]   A theory of fairness, competition, and cooperation [J].
Fehr, E ;
Schmidt, KM .
QUARTERLY JOURNAL OF ECONOMICS, 1999, 114 (03) :817-868
[22]  
Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007
[23]   Are people conditionally cooperative?: Evidence from a public goods experiment [J].
Fischbacher, U ;
Gächter, S ;
Fehr, E .
ECONOMICS LETTERS, 2001, 71 (03) :397-404
[24]   Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum [J].
Galvani, Alison P. ;
Reluga, Timothy C. ;
Chapman, Gretchen B. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (13) :5692-5697
[25]  
Haase N., MED DECISIO IN PRESS
[26]   TRAGEDY OF COMMONS [J].
HARDIN, G .
SCIENCE, 1968, 162 (3859) :1243-+
[27]   THE ROLES OF ALTRUISM, FREE RIDING, AND BANDWAGONING IN VACCINATION DECISIONS [J].
HERSHEY, JC ;
ASCH, DA ;
THUMASATHIT, T ;
MESZAROS, J ;
WATERS, VV .
ORGANIZATIONAL BEHAVIOR AND HUMAN DECISION PROCESSES, 1994, 59 (02) :177-187
[28]   Measles outbreaks in a population with declining vaccine uptake [J].
Jansen, VAA ;
Stollenwerk, N ;
Jensen, HJ ;
Ramsay, ME ;
Edmunds, WJ ;
Rhodes, CJ .
SCIENCE, 2003, 301 (5634) :804-804
[29]   Factors Affecting Intention to Receive and Self-Reported Receipt of 2009 Pandemic (H1N1) Vaccine in Hong Kong: A Longitudinal Study [J].
Liao, Qiuyan ;
Cowling, Benjamin J. ;
Lam, Wendy Wing Tak ;
Fielding, Richard .
PLOS ONE, 2011, 6 (03)
[30]   Optimal vaccination choice, vaccination games, and rational exemption: An appraisal [J].
Manfredi, Piero ;
Della Posta, Pompeo ;
d'Onofrio, Alberto ;
Salinelli, Ernesto ;
Centrone, Francesca ;
Meo, Claudia ;
Poletti, Piero .
VACCINE, 2009, 28 (01) :98-109